We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Dual antibody-aided mesoporous nanoreactor for H<sub>2</sub>O<sub>2</sub> self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer.
- Authors
Chen, Ying-Tzu; Luo, Ying-Xiang; Chan, Shih-Hsuan; Chiu, Wen-Yi; Yang, Hung-Wei
- Abstract
This document is a correction notice for an article titled "Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer" published in the Journal of Nanobiotechnology. The correction addresses an error in the funding information section, clarifying that the research was financially supported by the National Science and Technology Council, the National Health Research Institutes, and the Kaohsiung Armed Forces General Hospital in Taiwan. The original article has been corrected. The publisher, Springer Nature, maintains a neutral stance on jurisdictional claims and institutional affiliations.
- Subjects
KAO-hsiung shih (Taiwan); TAIWAN; TRIPLE-negative breast cancer; IMMUNOTHERAPY; NANOBIOTECHNOLOGY; RESEARCH institutes; NUCLEAR reactors
- Publication
Journal of Nanobiotechnology, 2023, Vol 21, Issue 1, p1
- ISSN
1477-3155
- Publication type
Correction Notice
- DOI
10.1186/s12951-023-02154-0